| pubmed-article:3105349 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3105349 | lifeskim:mentions | umls-concept:C0015684 | lld:lifeskim |
| pubmed-article:3105349 | lifeskim:mentions | umls-concept:C1704970 | lld:lifeskim |
| pubmed-article:3105349 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:3105349 | lifeskim:mentions | umls-concept:C0677040 | lld:lifeskim |
| pubmed-article:3105349 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:3105349 | lifeskim:mentions | umls-concept:C0008565 | lld:lifeskim |
| pubmed-article:3105349 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:3105349 | pubmed:dateCreated | 1987-5-20 | lld:pubmed |
| pubmed-article:3105349 | pubmed:abstractText | A chiral phase HPLC method was developed for the simultaneous determination of the positional and optical isomers of the lipoxygenase-derived hydroxypolyenoic fatty acids. With a Bakerbond chiral phase HPLC column (dinitrobenzoyl phenylglycine as chiral phase) the positional and optical isomers of the reduced dioxygenation products (by triphenylphosphine or borohydride) of linoleic acid and arachidonic acid were separated after methylation of the carboxylic groups. No cumbersome chemical derivatization such as conversion to a diastereomer was necessary. As compared with the methods used up till now chiral phase HPLC proved to be simpler and more sensitive. About 10 pmol of hydroxy fatty acids suffice for an analysis. The chiral phase HPLC can be used for the preparative separation of the optical antipodes of the lipoxygenase products. An optical purity of more than 90% can be reached in one preparative run. The method was applied to the determination of the stereochemistry of the dioxygenation products of polyenoic fatty acids formed by the lipoxygenases from soybeans, reticulocytes, pea seeds (isoenzyme I and II), tomato fruits, by the quasilipoxygenase activity of hemoglobin, and by the methylene blue-mediated photooxidation of arachidonic acid. | lld:pubmed |
| pubmed-article:3105349 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3105349 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3105349 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3105349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3105349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3105349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3105349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3105349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3105349 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3105349 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:3105349 | pubmed:issn | 0003-2697 | lld:pubmed |
| pubmed-article:3105349 | pubmed:author | pubmed-author:ScheweTT | lld:pubmed |
| pubmed-article:3105349 | pubmed:author | pubmed-author:LankinV ZVZ | lld:pubmed |
| pubmed-article:3105349 | pubmed:author | pubmed-author:KühnHH | lld:pubmed |
| pubmed-article:3105349 | pubmed:author | pubmed-author:WiesnerRR | lld:pubmed |
| pubmed-article:3105349 | pubmed:author | pubmed-author:AldenHH | lld:pubmed |
| pubmed-article:3105349 | pubmed:author | pubmed-author:NekrasovAA | lld:pubmed |
| pubmed-article:3105349 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3105349 | pubmed:volume | 160 | lld:pubmed |
| pubmed-article:3105349 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3105349 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3105349 | pubmed:pagination | 24-34 | lld:pubmed |
| pubmed-article:3105349 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:meshHeading | pubmed-meshheading:3105349-... | lld:pubmed |
| pubmed-article:3105349 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3105349 | pubmed:articleTitle | Analysis of the stereochemistry of lipoxygenase-derived hydroxypolyenoic fatty acids by means of chiral phase high-pressure liquid chromatography. | lld:pubmed |
| pubmed-article:3105349 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3105349 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3105349 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3105349 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3105349 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3105349 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3105349 | lld:pubmed |
